Ventana Medical receives FDA approval for new breast cancer genetic test

[News]

The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin, a commonly used breast cancer treatment.

More... (http://www.news-medical.net/news/20110615/Ventana-Medical-receives-FDA-approval-for-new-breast-cancer-genetic-test.aspx)